Project Grant R41AG090138
Award Date 9/20/25
Completion Date 5/31/27
Dollars Obligated $292K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cary, NC 27513, USA
Similar Awards
- This Cooperative Agreement award, totaling $943,301.00, was provided by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to the University of Southern California (USC). The award funds the pre-clinical development of two novel small molecule therapeutics for the treatment of idiopathic pulmonary fibrosis (IPF), a severe and fatal lung disease. Specifically, the grant supports research and development efforts on: 1) CX-1015, a GP130 small molecule...
- This $789,664 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a research project titled "Dissecting the Cellular and Spatial Tissue Clock of the Human Lung and Peripheral Blood" at the Icahn School of Medicine at Mount Sinai. The project aims to leverage single-cell RNA sequencing and spatial transcriptomics to characterize the effect of age on the cellular microenvironment of the human lung and peripheral blood. The research will...
- This federal Project Grant award of $461,146.00, provided by the National Institute on Aging (part of the U.S. Department of Health and Human Services) under the Aging Research program (CFDA 93.866), supports research at Yale University aimed at investigating the role of fibroblast growth factor receptor (FGFR) signaling in the pathogenesis of idiopathic pulmonary fibrosis (IPF). The key objectives are to (1) conduct in-vitro studies of FGFR isoform-specific signaling in primary lung cells and...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $639,740.00 to investigate the role of the CD38 enzyme in the development of chronic lung conditions following viral infections like COVID-19. The research aims to explore how targeting CD38 on CD8 tissue resident memory (TRM) cells could mitigate age-associated lung fibrosis after viral pneumonia. The award, effective December 15, 2024 through November 30, 2029, will support the lead researcher...
- This Project Grant award of $389,754 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to assess the therapeutic potential of a peptide derived from collagen XVIII for treating lung fibrosis associated with systemic sclerosis (scleroderma). The project aims to evaluate the anti-fibrotic effects of this peptide in a murine model of lung fibrosis, as well as identify the minimal effective dose, optimal...
- This federal Project Grant award from the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) provides $693,558 to the University of California, Los Angeles (UCLA) to validate the use of specific circulating biomarkers as functional response indicators for patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). The research aims to identify reliable early-stage biomarkers that can signal therapeutic efficacy,...
- This $463,625 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to better understand the effects of aging on the lung adenocarcinoma (LUAD) tumor microenvironment. The Icahn School of Medicine at Mount Sinai will use single-cell RNA sequencing and spatial analysis technologies to characterize age-related cellular and molecular changes in the LUAD tumor microenvironment. This research aims to uncover new therapeutic opportunities to modulate...
- This Project Grant award, provided by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866), aims to elucidate the role of reverse electron transport (RET) in lung aging and idiopathic pulmonary fibrosis (IPF). The $460,283 award to the University of California, San Francisco (UCSF) supports a 2-year investigation focused on two key objectives: 1) conducting a detailed gene expression analysis to understand RET's influence on pro-fibrotic gene...
- This $846,358 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to build a research platform to assess the senescence-associated secretory phenotype (SASP) in vivo. The goal is to elucidate the molecular identity of the SASP secretome and develop biomarkers to distinguish senescence and SASP signatures across different tissues. To accomplish this, the award will leverage a novel SASP-ER platform that permits conditional tagging of secreted proteins in...
- This federal Project Grant award of $291,913 was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to Virscio, Inc., a for-profit research company located in Connecticut. The award is focused on developing epigenetic and senescent biomarkers using non-human primate tissues to advance the understanding of biological aging processes and potential anti-aging strategies. The project aims to create minimally invasive biomarker tools, such as blood and skin-based assays,...